An Analysis of Financial Performance of Indian Pharmaceutical Companies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download An Analysis of Financial Performance of Indian Pharmaceutical Companies PDF full book. Access full book title An Analysis of Financial Performance of Indian Pharmaceutical Companies by CMA(Dr.) Ashok Panigrahi. Download full books in PDF and EPUB format.
Author: CMA(Dr.) Ashok Panigrahi
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Financial performance is a subjective measure of how well a firm can use assets from its primary mode of business and generate revenues. This term is also used as a general measure of a firm's overall financial health over a given period of time, and can be used to compare similar firms across the same companies or to compare companies or sectors in aggregation. A firm's performance measurement has been the subject matter of discussion for decision makers as managers, planners, economists and academic staff since long many years. Financial analysts often assess firm's production and productivity performance, profitability performance, liquidity performance, leverage performance, asset utilisation performance and growth performance. The financial performance analysis identifies the financial strengths and weaknesses of the firm by properly establishing relationships between the items of the balance sheet and profit and loss account. In this context researcher has undertaken an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. In this paper an attempt has been made to analyse the profitability position of five leading pharmaceutical companies of India with the help of mean, standard deviation, co-efficient of variation, multiple regression, and analysis of variance. The increase in profitability will not only yield greater efficiency but also improve financial performance in future. The study is conducted by taking into account of the data for five years from 2011-2012 to 2015-2016. The Pharmaceutical companies selected for study are Lupin, Wochkardt, Glenmark, Abott and Torrent. The financial performance of these companies are evaluated and found that the profitability of the selected pharmaceutical companies in India during the study period is satisfactory.
Author: CMA(Dr.) Ashok Panigrahi
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Financial performance is a subjective measure of how well a firm can use assets from its primary mode of business and generate revenues. This term is also used as a general measure of a firm's overall financial health over a given period of time, and can be used to compare similar firms across the same companies or to compare companies or sectors in aggregation. A firm's performance measurement has been the subject matter of discussion for decision makers as managers, planners, economists and academic staff since long many years. Financial analysts often assess firm's production and productivity performance, profitability performance, liquidity performance, leverage performance, asset utilisation performance and growth performance. The financial performance analysis identifies the financial strengths and weaknesses of the firm by properly establishing relationships between the items of the balance sheet and profit and loss account. In this context researcher has undertaken an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. In this paper an attempt has been made to analyse the profitability position of five leading pharmaceutical companies of India with the help of mean, standard deviation, co-efficient of variation, multiple regression, and analysis of variance. The increase in profitability will not only yield greater efficiency but also improve financial performance in future. The study is conducted by taking into account of the data for five years from 2011-2012 to 2015-2016. The Pharmaceutical companies selected for study are Lupin, Wochkardt, Glenmark, Abott and Torrent. The financial performance of these companies are evaluated and found that the profitability of the selected pharmaceutical companies in India during the study period is satisfactory.
Author: Mithun Nandy
Publisher: Springer Nature
ISBN: 981166921X
Category : Business & Economics
Languages : en
Pages : 224
Get Book Here
Book Description
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Author: P. Rohitkumar
Publisher: Infotech Publishers
ISBN: 9784158373520
Category : Business & Economics
Languages : en
Pages : 0
Get Book Here
Book Description
GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Author: Amalendu Bhunia
Publisher: LAP Lambert Academic Publishing
ISBN: 9783847315131
Category :
Languages : en
Pages : 172
Get Book Here
Book Description
Indian pharmaceutical industry has played a key role in promoting and sustaining development in the vital field of medicines. The goal of financial performance analysis is to determine the efficiency and performance of firm's management, as reflected in the financial reports. The analyst attempts to measure the firm's liquidity, profitability, and other indicators that the business is conducted in a rational and normal way; ensuring enough returns to the shareholders to maintain at least its market value. In this context an attempt has been made an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. The study has been undertaken for the period of twelve years from 1997-98 to 2008-09. In order to analyze financial performance, various accounting ratios and statistical techniques have been used. In this context an attempt has been made an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. The book is a modified version of research project report financially supported by UGC, India.
Author: CMA(Dr.) Ashok Panigrahi
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
A firm's performance measurement has been the subject matter of discussion for decision-makers as managers, planners, economists, and academic staff since long many years. It is the process of measuring the results of a firm's policies and operations in monetary terms. Financial performance analysis includes analysis and interpretation of financial statements in such a way that it undertakes the full diagnosis of the profitability and financial soundness of the business. This term is also used as a general measure of a firm's overall financial health over a given period of time and can be used to compare similar firms across the same companies or to compare companies or sectors in aggregation. Financial analysts often assess the firm's production and productivity performance, profitability performance, liquidity performance, leverage performance, asset utilization performance, and growth performance. The financial performance analysis identifies the financial strengths and weaknesses of the firm by properly establishing relationships between the items of the balance sheet and profit and loss account. In this paper, an attempt has been made to analyze the profitability position of five leading pharmaceutical companies in India with the help of mean, standard deviation, coefficient of variation, multiple regression, and analysis of variance. The results match with the earlier studies and the established theory of finance that the increase in profitability will not only yield greater efficiency but also improve financial performance in the future. The study is conducted by taking into account of the data for five years from 2011-2012 to 2015-2016. The Pharmaceutical companies selected for study are Lupin, Wockhardt, Glenmark, Abbott, and Torrent. The financial performance of these companies is evaluated and found that the profitability of the selected pharmaceutical companies in India during the study period is satisfactory.
Author:
Publisher:
ISBN: 9789388865340
Category :
Languages : en
Pages : 307
Get Book Here
Book Description
Author: Kidambi Padmini
Publisher: LAP Lambert Academic Publishing
ISBN: 9783659398704
Category :
Languages : en
Pages : 456
Get Book Here
Book Description
This book provides a mechanism which improves the efficiency, transparency, accountability of the pharmaceutical companies and builds the confidence of the stakeholders. It also helps in finding the root causes for failure of some pharmaceutical companies and find an appropriate solution to improve their performance. This book may also be useful to researchers, policy makers, research bodies and pharmaceutical companies. This book is sure of good source of information to the readers in general and the students and future researchers at large in particular.
Author: Mainak Mazumdar
Publisher: Physica
ISBN: 9783790828771
Category : Business & Economics
Languages : en
Pages : 202
Get Book Here
Book Description
This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Author: CMA(Dr.) Ashok Panigrahi
Publisher:
ISBN:
Category :
Languages : en
Pages : 24
Get Book Here
Book Description
Estimation of real worth of a stock is made by considering the earning potential of the company which depends on investment environment and factors relating to specific industry, competitiveness, quality of management, operational efficiency, profitability, capital structure and dividend policy. For investing in a company many people use fundamental analysis for the selection and technical analysis to make their buy and sell decisions. It relates to the examination of the intrinsic worth of a company to find out whether the current market price is fair or not, whether it is overpriced or underpriced. It is believed that analyzing the economy, strategy, management, product, financial status and other related information will help to choose shares that will outperform the market and provide consistent gains to the investor. It is the examination of the underlying forces that affect the interest of the economy, industrial sectors and companies. Here an attempt has been made to analyze the fundamental analysis through analyzing the financial performance of ten selected Pharma and Healthcare companies by using various statistical techniques. Torrent Pharmaceuticals stands as No. 1 company followed by Piramal which stood as the second.
Author: Kaushik Chakraborty
Publisher: LAP Lambert Academic Publishing
ISBN: 9783659379314
Category :
Languages : en
Pages : 320
Get Book Here
Book Description
In mid 1991, the Government at the Centre set in motion a new economic industrial policy after discarding the old Nehruvian line of socialistic pattern. Since then, various policy statements pronounced by the Government of India have the thrust towards deregulation, globalization and liberalisation. The globalization and liberalisation process of the country has made a path to MNCs to access the Indian markets resulting in intensified competition in market place. With the change in the economic scenario, a paradigm change in the Indian pharmaceutical industry has also become inevitable. In this backdrop, the present book makes an attempt to analyse the financial performance of some selected MNCs in Indian pharmaceutical industry during the ten-year period from 2001 to 2010.
